Managing patient pathways to achieve lung cancer waiting time targets: mixed methods study

Abstract

ObjectivesEngland's National Health Service (NHS) introduced a 62-day target, from referral to treatment, to make lung cancer patient pathways more efficient. This study aims to understand pathway delays that lead to breaches of the target when patients need care in both secondary and tertiary setting, so more than one institution is involved.DesignMixed methods cross case analysis.SettingTwo tertiary referral hospitals in London.ParticipantsDatabase records of 53 patients were analysed. Nineteen sets of patient notes were used for pathway mapping. Seventeen doctors, four nurses, eight managers and administrators were interviewed.Main outcome measuresQualitative methods include pathway mapping and semi-structured interviews. Quantitative analysis of patient pathway times from cancer services records.ResultsThe majority of the patient pathway (68.4%) is spent in secondary centres. There is more variability in the processes of secondary centres but tertiary centres do not have perfect processes either. Three themes emerged from discussions: information flows, pathway performance and the role of the multidisciplinary approach.ConclusionsThe actions of secondary centres have a greater influence on whether a patient breaches the 62-day target, compared with tertiary centres. Nevertheless variability exists in both, with potential for improvement.